These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20563581)

  • 21. Plasma and cerebrospinal fluid pharmacokinetics of the novel tetrahydroisoquinoline EDL-155 in rats.
    Song P; Ma F; Wang F; Wang X; Patil R; Ramagiri S; Orr WE; Miller DD; Geisert E; Yates CR
    Cancer Chemother Pharmacol; 2008 May; 61(6):1037-44. PubMed ID: 17768626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model.
    Berg SL; Reid J; Godwin K; Murry DJ; Poplack DG; Balis FM; Ames MM
    J Pediatr Hematol Oncol; 1999; 21(1):26-30. PubMed ID: 10029808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma and cerebrospinal fluid pharmacokinetic study of BNP1350 in nonhuman primates.
    Thompson PA; Berg SL; Aleksic A; Kerr JZ; McGuffey L; Dauser R; Nuchtern JG; Hausheer F; Blaney SM
    Cancer Chemother Pharmacol; 2004 Jun; 53(6):527-32. PubMed ID: 14997342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates.
    Blaney SM; Cole DE; Balis FM; Godwin K; Poplack DG
    Cancer Res; 1993 Feb; 53(4):725-7. PubMed ID: 8428353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma and cerebrospinal fluid pharmacokinetics of rebeccamycin (NSC 655649) in nonhuman primates.
    Berg SL; Aleksic A; McGuffey L; Dauser R; Nuchtern J; Bernacky B; Blaney SM
    Cancer Chemother Pharmacol; 2004 Aug; 54(2):127-30. PubMed ID: 15150671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid and Plasma Concentrations of Cefepime.
    Avedissian SN; Pais G; Joshi MD; Rhodes NJ; Scheetz MH
    mSphere; 2019 Jan; 4(1):. PubMed ID: 30700511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical drug metabolism and pharmacokinetics, and prediction of human pharmacokinetics and efficacious dose of the investigational Aurora A kinase inhibitor alisertib (MLN8237).
    Yang JJ; Li Y; Chakravarty A; Lu C; Xia CQ; Chen S; Pusalkar S; Zhang M; Ecsedy J; Manfredi MG; Wu JT; Shyu WC; Balani SK
    Drug Metab Lett; 2014 Jul; 7(2):96-104. PubMed ID: 24484538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma and cerebrospinal fluid pharmacokinetics of O6-benzylguanine and analogues in nonhuman primates.
    Long L; Berg SL; Roy SK; McCully CL; Song-Yoo HW; Moschel RC; Balis FM; Dolan ME
    Clin Cancer Res; 2000 Sep; 6(9):3662-9. PubMed ID: 10999759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mass balance, routes of excretion, and pharmacokinetics of investigational oral [
    Zhou X; Pusalkar S; Chowdhury SK; Searle S; Li Y; Ullmann CD; Venkatakrishnan K
    Invest New Drugs; 2019 Aug; 37(4):666-673. PubMed ID: 30397836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical assessment of the absorption and disposition of the phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor GDC-0980 and prediction of its pharmacokinetics and efficacy in human.
    Salphati L; Pang J; Plise EG; Lee LB; Olivero AG; Prior WW; Sampath D; Wong S; Zhang X
    Drug Metab Dispos; 2012 Sep; 40(9):1785-96. PubMed ID: 22696419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates.
    Patel M; McCully C; Godwin K; Balis FM
    J Neurooncol; 2003 Feb; 61(3):203-7. PubMed ID: 12675312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420.
    Broniscer A; Panetta JC; O'Shaughnessy M; Fraga C; Bai F; Krasin MJ; Gajjar A; Stewart CF
    Clin Cancer Res; 2007 Mar; 13(5):1511-5. PubMed ID: 17332296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A supported liquid extraction-LC-MS/MS method for determination of GDC-0980 (Apitolisib), a dual small-molecule inhibitor of class 1A phosphoinositide 3-kinase and mammalian target of rapamycin, in human plasma.
    Ding X; Li F; McKnight J; Schmidt C; Strooisma K; Shimizu H; Faber K; Ware JA; Dean B
    J Pharm Biomed Anal; 2014 Nov; 100():150-156. PubMed ID: 25165011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma and cerebrospinal fluid pharmacokinetics of 9-aminocamptothecin (9-AC), irinotecan (CPT-11), and SN-38 in nonhuman primates.
    Blaney SM; Takimoto C; Murry DJ; Kuttesch N; McCully C; Cole DE; Godwin K; Balis FM
    Cancer Chemother Pharmacol; 1998; 41(6):464-8. PubMed ID: 9554590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma and cerebrospinal fluid pharmacokinetics of vincristine and vincristine sulfate liposomes injection (VSLI, marqibo®) after intravenous administration in Non-human primates.
    Shah NN; Cole DE; Lester-McCully CM; Wayne AS; Warren KE; Widemann BC
    Invest New Drugs; 2016 Feb; 34(1):61-5. PubMed ID: 26661090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma and cerebrospinal fluid pharmacokinetics of tasidotin (ILX-651) and its metabolites in non-human primates.
    Kilburn LB; Bonate PL; Blaney SM; McGuffey L; Nuchtern JG; Dauser R; Thompson P; Gibson BW; Berg SL
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):335-40. PubMed ID: 19043710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An LC/ESI-MS/MS method to quantify the PI3K inhibitor GDC-0084 in human plasma and cerebrospinal fluid: Validation and clinical application.
    Zhong B; Campagne O; Tinkle CL; Stewart CF
    Biomed Chromatogr; 2020 Jan; 34(1):e4697. PubMed ID: 31495945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of the protease inhibitor KNI-272 in plasma and cerebrospinal fluid in nonhuman primates after intravenous dosing and in human immunodeficiency virus-infected children after intravenous and oral dosing.
    Mueller BU; Anderson BD; Farley MQ; Murphy R; Zuckerman J; Jarosinski P; Godwin K; McCully CL; Mitsuya H; Pizzo PA; Balis FM
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1815-8. PubMed ID: 9661027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry.
    Liu MY; Meng SN; Wu HZ; Wang S; Wei MJ
    Clin Ther; 2008 Apr; 30(4):641-53. PubMed ID: 18498913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penetration of SCH-39304, a new antifungal triazole, into cerebrospinal fluid of primates.
    Walsh TJ; Lester-McCully C; Rinaldi MG; Wallace JE; Balis FM; Lee JW; Pizzo PA; Poplack DG
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1281-4. PubMed ID: 2393291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.